Multiple panel and CEO-led discussions at the 2025 MedTech conference in San Diego, noted a recent decline in MedTech M&A deals. They also highlighted a decrease in venture financing rounds for MedTech firms and emphasised the growing need for investment in early-stage MedTech companies. GlobalData analysis supports these conclusions. Figure 1 displays the annual deal count for 15 of the largest MedTech companies starting in 2015. While there is still time for more deals to occur in 2025, there is a notab ...